insights_auto
Nega NBIX tushdi 4,41%?
Batafsil oสปrganishchevron_right
NBIX:NASDAQ
Neurocrine Biosciences, Inc
135,13ย US$
arrow_downward
-4,41%(-6,24) 1K
134,86ย US$
arrow_downward
-0,20% (-0,27)todayBirjadan oldin
Savdolar yopilgan: 13-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oสปzgartirishlar | Dinamika (%) |
|---|
insights_autoNBIX tikeri uchun statistika yaratilmoqda...
Ochish
139,60ย US$
Yuqori
139,92ย US$
Past
134,89ย US$
Bozor kapitali
13,74ย mlrd
Oสปrtacha hajm
1,30ย mln
Hajmi
875,00
P/E koeffitsiyenti
19,81
52 haftalik eng yuqori
186,12ย US$
52 haftalik eng past
122,14ย US$
Aksiya boสปyicha daromad
6,82ย US$
Beta
0,40
Muomaladagi aksiyalar
101,65ย mln
Xodimlar soni
2ย ming
Ochish
139,60ย US$
Yuqori
139,92ย US$
Past
134,89ย US$
Bozor kapitali
13,74ย mlrd
Oสปrtacha hajm
1,30ย mln
Hajmi
875,00
P/E koeffitsiyenti
19,81
52 haftalik eng yuqori
186,12ย US$
52 haftalik eng past
122,14ย US$
Aksiya boสปyicha daromad
6,82ย US$
Beta
0,40
Muomaladagi aksiyalar
101,65ย mln
Xodimlar soni
2ย ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Barron's
·
11 soat oldin
This Biopharma Stock Offers Compelling Upside After a Pullback
GuruFocus
·
13 soat oldin
Is Neurocrine Biosciences Inc (NBIX) a Bargain After 4.4% Drop? GF Value Says Undervalued
Insider Monkey
·
17 soat oldin
Axsome Therapeutics (AXSM) vs. Neurocrine Biosciences (NBIX): Is Faster Growth Worth Paying More For?
Zacks
·
19 soat oldin
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?
Profil
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Neurocrine Biosciences, Inc haqida
CEOKevin C. Gorman
Xodimlar soni2,5ย ming
Asos solingan1992
Bosh ofislarSan Diego, Kaliforniya, Amerika Qoโshma Shtatlari
Sektor-
Veb-saytneurocrine.com